Most just lately, it's been discovered that conolidine and the above derivatives act within the atypical chemokine receptor three (ACKR3. Expressed in very similar locations as classical opioid receptors, it binds to the big range of endogenous opioids. Not like most opioid receptors, this receptor functions as a scavenger https://taylorm642fij3.blogoscience.com/profile